Halozyme Therapeutics, Inc. logo

Halozyme Therapeutics, Inc. (HALO)

$53.85

Halozyme Therapeutics, Inc. (HALO) Share Price Forecast
Currently 17 wall-street analysts regularly analyze the financials of Halozyme Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Halozyme Therapeutics, Inc. (HALO) have a share price target of $61.56. This median of share price forecast represents a 14.32% upside from the latest price of $53.85 as on 08.10.24.

Halozyme Therapeutics, Inc. (HALO) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Halozyme Therapeutics, Inc. (HALO) share price will touch around $61.56 in next 12-months.
Halozyme Therapeutics, Inc. (HALO) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Halozyme Therapeutics, Inc.'s share price and its median forecast price. As on 08.10.24, the difference is -7.99%

Halozyme Therapeutics, Inc. (HALO): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Halozyme Therapeutics, Inc. (HALO) Share Price : Analyst Recommendation
Based on 17 analysts tracking and researching Halozyme Therapeutics, Inc. (HALO) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
11
12
12
Outperform
2
2
2
Hold
3
3
3
Underperform
1
0
0
Sell
0
0
0
Halozyme Therapeutics, Inc. (HALO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Halozyme Therapeutics, Inc. (HALO) is $61.56, offered by 17 analysts offering 12-month price forecasts.

Halozyme Therapeutics, Inc. (HALO) has a maximum of 0.14 upside potential, based on 17 analysts offering 12-month price forecasts.

Based on 17 analysts tracking and researching Halozyme Therapeutics, Inc. (HALO), 82.35% have a buy recommendation. Remaining 17.65% have either sell or hold recommendations.

The latest share price of Halozyme Therapeutics, Inc. (HALO) is $53.85 as of 08/10/2024.

14 of total 17 analysts offering stock ratings for Halozyme Therapeutics, Inc. HALO have recommended buy rating.